| abstract |
The present invention relates to pyrazolo-pyrimidine derivatives of the formula (I): (see formula (I)), wherein from R1 to R4 and A have the meanings defined in the description, to a process for obtaining the same, to its use for the treatment or prevention of disorders mediated by metabotropic glutamate receptors, to its use for the manufacture of medicaments intended for the treatment of said disorders and to pharmaceutical compositions containing such derivatives. |